Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice

[1]  I. Tohnai,et al.  Heat and mechanical hyperalgesia in mice model of cancer pain , 2005, Pain.

[2]  P. Mantyh,et al.  Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization , 2005, Pain.

[3]  C. Stucky,et al.  Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse , 2005, Pain.

[4]  N. Carruthers,et al.  Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.

[5]  C. Bantel,et al.  Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased α2C-adrenoceptor co-expression and functional inhibition by clonidine , 2005, Pain.

[6]  Q. Sun,et al.  Current perspectives on the therapeutic utility of VR1 antagonists. , 2004, Current medicinal chemistry.

[7]  Michael A. Kuskowski,et al.  Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis , 2004, Pain.

[8]  A. Lastra,et al.  The analgesic effect induced by capsaicin is enhanced in inflammatory states. , 2004, Life sciences.

[9]  M. Iadarola,et al.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. , 2004, The Journal of clinical investigation.

[10]  R. Moore,et al.  Systematic review of topical capsaicin for the treatment of chronic pain , 2004, BMJ : British Medical Journal.

[11]  Yong Chen,et al.  Resiniferatoxin reversibly blocks adjuvant-induced thermal hyperalgesia in the rat. , 2003, European journal of pharmacology.

[12]  S. Llames,et al.  Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain , 2003, Brain Research.

[13]  Masaki Tanaka,et al.  Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons , 2003, Brain Research.

[14]  P. McIntyre,et al.  The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[15]  G. Maskarinec,et al.  The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women , 2002, BMC women's health.

[16]  A. Lastra,et al.  Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice , 2002, Journal of Neuroscience Methods.

[17]  P. Mantyh,et al.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord , 2000, Nature Medicine.

[18]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[19]  W. T. Lee,et al.  A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance , 1998, Neuroscience.

[20]  E. Campbell,et al.  Capsazepine reversal of the antinociceptive action of capsaicin in vivo , 1992, British journal of pharmacology.